| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |